Doxazosin versus bendrofluazide: a comparison of the metabolic effects in British South Asians with hypertension.

Abstract

BACKGROUND People from British South Asian communities have an increased risk of mortality from coronary heart disease (CHD). Doxazosin, a selective alpha(1)-adrenergic blocker, in addition to lowering blood pressure, has been shown to have positive effects on glucose metabolism and lipid profiles in patients with hypertension. AIM We studied doxazosin (1… (More)

Topics

4 Figures and Tables